Nextleaf Solutions Ltd (CSE:OILS, OTCQB:OILFF) announced that its Glacial Gold Distilled CBD 200 Oil is now available nationally in Canada through its medical cannabis distribution partner Medicibis (Mendo).

Glacial Gold CBD and THC vapes and distilled oils are available through Mendo, via an online portal for medical patients that ships across Canada.

Vancouver-based Nextleaf launched Glacial Gold CBD and THC products for the medical market through Mendo as part of its commitment to improving access to medical cannabis, it said in a statement.

SiliCycle Inc., a company working in the health field, founded and established in Quebec, takes a major step allowing it to directly reach medical customers. The company has obtained approval to sell directly to consumers with a prescription for medical cannabis. It is through its subsidiary PurCann Pharma and under the OOVIE ™ medical brand that the first products will be available on the Quebec and Canadian markets in the coming weeks.

Nicholas Sosiak, CFO of Cannara Biotech Inc., discusses the accelerated retail price compression of cannabis products

Price skimming is a common pricing strategy that companies use to maximize profits by initially charging the highest possible price in any new industry and gradually discounting prices over time to address a broader and more price sensitive segment of the market.

Three years into cannabis legalization, we’re now seeing an accelerated retail price compression, which is favourable for the consumers but not all producers are prepared to support this downward price trend.

In Quebec, the most commonly sold product is the 3.5 gram dried flower, which accounts for the majority of all dried flower sales.

Top Canadian Marijuana Stocks To Buy In 2022? These Could Be The Ones To Watch

Company selects NEO to access wider investor base and enhanced liquidity

NEO is proud to welcome Trees Corporation ("Trees" or the "Company"), a premier Canadian cannabis retailer, as they list today on the NEO Exchange. Trees is now available for trading on NEO under the symbol TREE.

Deeply rooted in the cannabis community, and serving as a respected voice of advocacy for cannabis legalization, there are ten Trees branded storefronts in Canada, including six stores owned and operated in Ontario by Trees, and four additional stores operated by 1015712 B.C. Ltd ("101") in British Columbia.

On January 10, Tilray soundly beat second-quarter earnings estimates. Here's why TLRY is on track to become the worldwide weed market leader.

Get Tilray, Inc. Report reported solid numbers in its second-quarter earnings results. The Canada-based marijuana company surprised Wall Street estimates by reporting a reversal from the $89 million net loss recorded in the same period last year to $6 million in net income.

In addition, Tilray grew revenues by 20%, compared with last quarter, and posted its 11th consecutive quarter of positive earnings before interest, taxes, depreciation, and amortization (EBITDA).

On Friday, the Prince George Airport Authority in British Columbia welcomed a new business partner, which is pioneering cannabis for travel.

A cannabis dispensary at an airport? Could this be true?

Apparently, it could happen sooner rather than later. Where? Canada, of course, and most likely at the Prince George Airport (IATA: YXS) (ICAO: CYXS), which serves Prince George, British Columbia and the surrounding areas.

Last year was a mixed bag of a year for Canadian marijuana investors. Speculation about the future of the sector fluctuated wildly as talks about federal legalization heated up in the United States and recreational cannabis prices reached historic lows. Additionally, players in the Canadian cannabis space are waiting with bated breath for the three-year review of the country’s cannabis legislation by federal lawmakers. The review began in December 2021, and the health minister will present the department’s findings and recommendations in 2023.

Canadian LPs For Your 2022 Watchlist

Are you looking for the best marijuana stocks to buy in January 2022? At the current time, much of the cannabis sector is trading near its 52-week lows to start the new year. These declines are mostly related to the delays with federal cannabis legalization in Congress. Now that many cannabis stocks have given back most of the upside since the presidential election in November of 2020, they could be trading at better investment levels.

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.

On January 7, 2022 Canntab completed its first shipment of 5 mg THC tablets to the Ontario Cannabis Store ("OCS"). Additionally, in early December 2021, Canntab completed its second shipment of both THC and CBD tablets to Australia.